Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience

Williams B, Menon M, Satran D, et al. Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3‑year mortality. Catheter Cardiovasc Interv. 2010;75:886–91.

Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina; report from the ESC joint study group on the treatment of refractory angina. Eur Heart J. 2002;23:355–70.

Bhatt AB, Stone PH. Current strategies for the prevention of angina in patients with stable coronary artery disease. Curr Opin Cardiol. 2006;21:492–502.

Chow CM, Donovan L, Johansen H. Regional variation in self-reported heart disease prevalence in Canada. Can J Cardiol. 2005;21:1265–71.

McGillion M, Arthur HM, Cook A, et al. Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines. Can J Cardiol. 2012;28(2 Suppl):20–41.

Leon MB, Kornowski R, Downey WE, et al. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol. 2005;46:1812–9.

Henry TD, Satran D, Jolicoeur EM. Treatment of refractory angina in patients not suitable for revascularization. Nat Rev Cardiol. 2014;11:78–95.

McNab D, Khan SN, Sharples LD, et al. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. Eur Heart J. 2006;27:1048–53.

Weisz G, Généreux P, Iñiguez A, et al. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016;387:9–15.

Sato M, Saito T, Mitsugi M, et al. Effects of cardiac contraction and coronary sinus pressure elevation on collateral circulation. Am J Physiol. 1996;271(4 Pt 2):H1433–H1440.

Ido A, Hasebe N, Matsuhashi H, Kikuchi K. Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemia. Am J Physiol Heart Circ Physiol. 2001;280:H1361–H1367.

Rouleau JR, White M. Effects of coronary sinus pressure elevation on coronary blood flow distribution in dogs with normal preload. Can J Physiol Pharmacol. 1985;63:787–97.

Banai S, Muvhar BS, Parikh KH, et al. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol. 2007;49:1783–9.

Gross L, Blum L, Silverman G. Experimental attempts to increase the blood supply to the dog’s heart by means of coronary sinus occlusion. J Exp Med. 1937;65:91–108.

Beck CS, Leighninger DS. Operations for coronary artery disease. J Am Med Assoc. 1954;156:1226–33.

Konigstein M, Meyten N, Verheye S, Schwartz M, Banai S. Transcatheter treatment for refractory angina with the coronary sinus reducer. EuroIntervention. 2014;9:1158–64.

Banai S, Schwartz M, Sievert H, et al. Long term follow-up to evaluate the safety of the neovasc reducer A device-based therapy for chronic refractory angina. annual scientific session of the american college of cardiology. J Am Coll Cardiol. 2010;(A98):E927–A980. doi: 10.1016/S0735-1097(10)60928-X .

Verheye S, Jolicœur EM, Behan MW, et al. Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med. 2015;372:519–27.

Jolicœur EM, Banai S, Henry TD, et al. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial. Trials. 2013;14:46.

Stoller M, Traupe T, Khattab AA, et al. Effects of coronary sinus occlusion on myocardial ischaemia in humans: role of coronary collateral function. Heart. 2013;99:548–55.

Feigl E. The paradox of adrenergic coronary vasoconstriction. Circulation. 1987;76:737–45.

Hahn RS, Kim M. Revascularization of the heart; histologic changes after arterialization of the coronary sinus. Circulation. 1952;5:810–5.

Hoef TP van de, Nijveldt R, Ent M van der, et al. Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the prepare RAMSES safety and feasibility study. EuroIntervention. 2015;11:37–44.

Mohl W, Gangl C, Jusić A, et al. PICSO: from myocardial salvage to tissue regeneration. Cardiovasc Revasc Med. 2015;16:36–46.

Ansari A. Anatomy and clinical significance of ventricular thebesian veins. Clin Anat. 2001;14:102–10.

Ghani A, Delnoy PP, Ramdat MAR, et al. Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation. Neth Heart J. 2014;22:286–91.